Heterogeneity for integrin expression and cytokine‐mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins
- 20 February 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 47 (4) , 551-559
Abstract
Expression of α and β subunits of VLA and VNR integrins was analyzed by cytofluorimetric analysis on 6 different human primary and metastatic melanoma cell cultures. Marked inter‐tumor heterogeneity was observed, and expression of VLA‐α, VLA‐α2 and VLA‐α6 was lower on primary melanomas than on metastatic lesions. The function of VLA products on melanoma cells was assessed by adhesion assays to extracellular matrix (ECM) proteins using a panel of melanoma clones previously characterized for the presence and heterogeneity of expression of the distinct VLA‐α subunits. These experiments indicated that intra‐tumor heterogeneity in the integrin profile can influence the interaction of neoplastic cells with ECM proteins. Inhibition of adhesion with antibodies to VLA‐α subunits revealed that the presence on melanoma cells of VLA‐α2, VLA‐α5 and VLA‐α6 is relevant for the adhesion to type‐IV collagen, fibronectin and laminin respectively. Culture of tumor cells in the presence of cytokines such as rIL‐1β, rTNF‐α, rIFN‐γ or TGF‐β could induce up‐ or down‐modulation in the level of expression of multiple VLA integrins. Cytokine‐mediated antigenic shifts in the VLA profile of melanoma cells were detected by cytofluorimetric analysis as early as 24 hr after cytokine exposure. The cytokine‐dependent change in the matrix receptor profile of melanoma cells also affected the adhesion to ECM proteins as revealed by the enhanced adhesion of rTNF‐α‐treated cells to fibronectin. These data indicate that constitutive heterogeneity in the integrin profile or cytokine‐mediated shifts in VLA expression can affect the ability of human melanoma cells to interact with different ECM components.Keywords
This publication has 27 references indexed in Scilit:
- Human melanoma cells with high susceptibility to cell‐mediated lysis can be identified on the basis of icam‐1 phenotype, vla profile and invasive abilityInternational Journal of Cancer, 1990
- The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells.Journal of Cell Biology, 1990
- VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding siteCell, 1990
- The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others.Proceedings of the National Academy of Sciences, 1989
- Modulation of Laminin Receptor Expression by Estrogen and Progestins in Human Breast Cancer Cell LinesJNCI: Journal of the National Cancer Institute, 1989
- A novel vitronectin receptor integrin (αvβx) is responsible for distinct adhesive properties of carcinoma cellsCell, 1989
- Human vascular endothelial cells express a membrane protein complex immunochemically indistinguishable from the platelet VLA-2 (glycoprotein Ia-IIa) complexBlood, 1989
- Regulation of expression of the cell adhesion receptors, integrins, by recombinant human interleukin‐1β in human osteosarcoma cells: Inhibition of cell proliferation and stimulation of alkaline phosphatase activityJournal of Cellular Physiology, 1989
- Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon γInternational Journal of Cancer, 1986
- Monoclonal antibodies specific for platelet glycoproteins react with human monocytesBlood, 1984